Selective Destruction of Cultured Dopaminergic Neurons from Fetal Rat Mesencephalon by 1‐Methyl‐4‐Phenylpyridinium: Cytochemical and Morphological Evidence

Journal of Neurochemistry

Volumn 50, Issue 6, 1988, Pages 1934-1944

  Sanchez‐Ramos, Juan R ^a   Michel, Patrick ^a   Weiner, William J ^a   Hefti, Franz ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

1 Methyl 4 phenylpyridinium; 1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Antioxidants; Cell cultures; Dopamine; Neurotoxicity; Paraquat

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; BRAIN; CYTOCHEMISTRY; DOPAMINERGIC NERVE CELL; FETUS; MESENCEPHALON; NERVE CELL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMAL; ANTIOXIDANTS; CATECHOLAMINES; CELLS, CULTURED; COMPARATIVE STUDY; DOPAMINE; HISTOCYTOCHEMISTRY; IMMUNOENZYME TECHNIQUES; KINETICS; MESENCEPHALON; MICROSCOPY, FLUORESCENCE; NEURONS; NEUROTOXINS; PYRIDINIUM COMPOUNDS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TYROSINE 3-MONOOXYGENASE;

EID: 0023916509     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb02500.x     Document Type: Article

References (64)

1. The possible relation of glutathione, melanin and MPTP to Parkinson's disease
2. Long term development of mesencephalic dopaminergic neurons of mouse embryos in dissociated primary cultures: morphological and histochemical characteristics
3. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
4. Potential bioactivation pathways for the neurotoxin MPTP
5. + on endogenous dopamine release from rat corpus striatum superfused in vitro
6. Neurochemical and behavioral effects of systemic and intra‐nigral administration of N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the rat
7. Oxy‐radical toxicity in catecholamine neurons
8. Studies on the mechanism of action of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
9. Pargyline and deprenyl prevent the neurotoxicity of MPTP in the monkey
10. Evidence for neuromelanin involvement in MPTP‐induced neurotoxicity
11. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
12. An improved approach to histofluorescence using the SPG method for tissue monoamines
13. Histochemical fluorescence of tissue and brain monoamines: results in 18 minutes using the sucrose‐phosphate‐glyoxylic acid (SPG) method
14. Acute administration of MPTP reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP
15. Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
16. Neurotoxicity of the meperidine analogue N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) on brain catecholamine neurons in the mouse
17. Neurochemical and histochemical characterization of neurotoxic effects of MPTP on brain catecholamine neurons in the mouse
18. On the mechanisms underlying 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) neurotoxicity: the effect of perinigral infusion of MPTP, its metabolite and their analogs in the rat
19. Further studies on the generation of hydrogen peroxide by 6‐OHdopamine: potentiation by ascorbic acid
20. In vivo generation of hydrogen peroxide from 6‐OHdopamine
21. Dopaminergic neurotoxicity of MPTP in mice
22. Effects of MPTP on neostriatal dopamine in mice
23. Protection against the dopaminergic neurotoxicity of MPTP by monoamine oxidase inhibitors
24. Studies in the oxidation of the dopamine neurotoxin MPTP by monoamine oxidase B
25. Effects of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice
26. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1‐methyl‐4‐phenylpyridinium ion
27. +, on tyrosine hydroxylation in rat striatal tissue slices
28. + by dopaminergic neurons explains selectivity of parkinsonism inducing neurotoxin MPTP
29. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonism in the common marmoset
30. Differences in metabolism of MPTP in rodent and primate brain parallel differences in sensitivity to its neurotoxic effects
31. MPTP neurotoxicity: correlation with blood‐brain‐barrier monoamine oxidase activity
32. Serum factor supporting long term survival of rat central neurons in culture
33. Paraquat and Parkinson's disease
34. Chronic parkinsonism due to a product of a meperidine analog synthesis
35. Pargyline prevents MPTP‐induced parkinsonism in primates
36. The importance of the 4–5′ double bond for neurotoxicity in primates of the pyridine derivative MPTP
37. Selective nigral toxicity after systemic administration of MPTP in the squirrel monkey
38. Dopamine and norepinephrine containing neuron systems: their anatomy in the rat brain
39. Intraneuronal accumulation of a pyridinium metabolite may produce MPTP‐induced parkinsonian syndrome in monkey
40. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of MPTP
41. Prevention of the nigrostriatal toxicity of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine by inhibitors of 3,4‐dihydroxyphenylethylamine transport
42. Effects of repeated systemic administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content
43. MPTP destroys DA neurons in explants of rat embryo mesencephalon
44. Deprenyl protects dopamine neurons from the neurotoxic effect of 1‐methyl‐4‐phenylpyridinium ion
45. + is toxic to mesencephalic dopaminergic neurons in culture
46. Inhibition of NADH‐linked oxidation in brain mitochondria by 1‐methyl‐4‐phenylpyridinium, a metabolite of the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
47. Partial protection from the dopaminergic neurotoxin MPTP by four different antioxidants in the mouse
48. Catecholamine‐uptake inhibitors prevent the neurotoxicity of MPTP in mouse brain
49. + induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase
50. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism
51. +
52. Fate of nigrostriatal neurons in young mice given 1‐methyl‐4‐phenyl‐1,2,3.6‐tetrahydropyridine: a neurochemical and morphological reassessment
53. N‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat
54. +, but not MPTP is toxic to dopamine neurons in cultures of dissociated rat mesencephalic neurons
55. +) oxidizes cytochrome b in rat striatal slices
56. Protection against MPTP neurotoxicity by the antioxidant ascorbic acid
57. Biochemical events in the development of parkinsonism induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
58. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease
59. Neurotoxic damage to nigrostriatal system following intranigral administration of the oxidative metabolites (MPDP and MPP) of MPTP
60. +
61. Ascorbic acid reduces the dopamine depletion induced by MPTP
62. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1‐methyl‐4‐phenyl pyridinium ion
63. Effect of MPTP on monoamines neurotransmitters in mouse brain and heart
64. Depletion of glutathione in brainstem of mice caused by MPTP is prevented by antioxidant pretreatment